Surgepays is trading at $0.25, down 10.64% in pre-market, with no new company-specific announcement found for August 17, 2026, to explain the decline.
- Surgepays reported Q2 revenue of $16.20 million, up 40.7%, and $1.29 million in net income on August 14.
- The positive earnings release does not directly explain the pre-market drop.
- Broader indexes were essentially mixed and little changed.